Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focusesOn |
developing therapies for chronic and serious medical conditions
|
| gptkbp:formerName |
AntriaBio, Inc.
|
| gptkbp:foundedYear |
2007
|
| gptkbp:fullName |
Adhera Therapeutics, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Durham,_North_Carolina,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ADRX
|
| gptkbp:website |
https://adheratherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Andrx_Corporation
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
ADRX
|